Emerald Health Therapeutics Stock News

Skye Bioscience Inc (OTCQB:SKYE) announced that it has concluded the merger with Emerald Health Therapeutics after both companies' shareholders voted in favor and the Supreme Court of British Columbia

Skye Bioscience Inc (OTCQB:SKYE) has announced that the shareholders of Emerald Health Therapeutics Inc (CSE:EMH, OTCQX:EMHTF) have approved the proposed plan of arrangement which will result in the i

Skye Bioscience Inc (OTCQB:SKYE) and Emerald Health Therapeutics Inc said they have entered into a definitive agreement that will see Skye acquiring Emerald in a share-for-share transaction. Under th

HYTN Innovations Inc.s (CSE:HYTN) subsidiary HYTN Cannabis Inc. , has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers. National sales of HYTN''s cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX: EMHTF ) (CSE:EMH). Subsequently, Emerald announced a change in business strategy that Full story available on Benzinga.com

Emerald Health Therapeutics, Inc. (CSE:EMH) (OTCQX:EMHTF) announced Monday that it is getting out of the recreational and medical cannabis industry and pivoting to pharmaceutical development. The c

A new market study, titled Medical Marijuana Market Forecast 2021-2028 has been featured on Fortune Business Insights. ***Get Latest Updated Market Research Report with Sample Report Market Overview: The global medical marijuana market size is expected to reach USD 26,920.4 million by 2028,

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today that its Chief Financial Officer, Jenn Hepb

Emerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q2 2021 Results - Earnings Call Transcript

Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald")  has released its financial results for the three and six mon

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will report its financial results fo

Vancouver, British Columbia--(Newsfile Corp. - August 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed Nick Mosgrove as VP Sales & Marketing. Mr. Mosgr

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that Avtar Dhillon, MD, has resigned from his r

Vancouver, British Columbia--(Newsfile Corp. - July 23, 2021) -  Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald")  has retained BC Farm & Ranch Realty Corp., a real estate age

Emerald secures equity position in US company launching unique cannabis specialty productVancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTC

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed Mr. Moe Jiwan as Chief Operating Officer effective